Skip to main content

Table 2 Acute (defined as within 90 days of radiation treatment) and late (greater than 90 days after radiation treatment) toxicities after radiotherapy, as quantified by CTCAE schema

From: Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

 

Acute toxicities

Late toxicities

Dysgeusia

  

 Grade 0

4 (12%)

4 (12%)

 Grade 1

19 (56%)

22 (65%)

 Grade 2

11 (32%)

8 (24%)

 Grade 3

0 (0%)

0 (0%)

Dysphagia

  

 Grade 0

1 (3%)

4 (12%)

 Grade 1

18 (53%)

11 (32%)

 Grade 2

11 (32%)

14 (41%)

 Grade 3

4 (12%)

5 (15%)

Pain

  

 Grade 0

1 (3%)

4 (12%)

 Grade 1

8 (24%)

14 (41%)

 Grade 2

21 (62%)

14 (41%)

 Grade 3

4 (12%)

2 (6%)

Xerostomia

  

 Grade 0

0 (0%)

0 (0%)

 Grade 1

17 (50%)

27 (79%)

 Grade 2

17 (50%)

7 (21%)

 Grade 3

0 (0%)

0 (0%)